Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
8-K
Myomo Appoints Heather Getz to its Board of Directors
28 Mar 24
10-K
2023 FY
Annual report
7 Mar 24
8-K
Myomo Reports Fourth Quarter and Full Year 2023 Financial Results
7 Mar 24
8-K
Other Events
1 Mar 24
8-K
Departure of Directors or Certain Officers
22 Feb 24
8-K
Myomo Reports Preliminary Fourth Quarter Revenue and Backlog
17 Jan 24
424B5
Prospectus supplement for primary offering
17 Jan 24
8-K
Departure of Directors or Certain Officers
19 Dec 23
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations
7 Nov 23
8-K
CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting
6 Nov 23
8-K
Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category
2 Nov 23
8-K
Entry into a Material Definitive Agreement
28 Aug 23
424B5
Prospectus supplement for primary offering
28 Aug 23
424B5
Prospectus supplement for primary offering
24 Aug 23
424B5
Prospectus supplement for primary offering
24 Aug 23
8-K
Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims
24 Aug 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
8-K
Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics
9 Aug 23
S-8
Registration of securities for employees
28 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
9 Jun 23
10-Q
2023 Q1
Quarterly report
10 May 23
8-K
Myomo Reports First Quarter 2023 Financial Results Featuring 20% Year Over Year Increase in Product Revenue
10 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
8-K
Myomo Receives Technology License Fee Payment from China Joint Venture Company
10 Apr 23
10-K
2022 FY
Annual report
13 Mar 23
8-K
Myomo Reports Fourth Quarter and Full Year 2022 Financial Results
13 Mar 23
8-K
Myomo Appoints Yitzchak Jacobovitz to its Board of Directors
30 Jan 23
EFFECT
Notice of effectiveness
17 Jan 23
8-K
Entry into a Material Definitive Agreement
13 Jan 23
424B4
Prospectus supplement with pricing info
13 Jan 23
S-1MEF
Registration of additional securities for an S-1
11 Jan 23
S-1/A
IPO registration (amended)
10 Jan 23
8-K
Myomo Announces Initiative to Reduce Cash Burn
10 Jan 23
S-1/A
IPO registration (amended)
10 Jan 23
Latest ownership filings
SC 13G/A
Rosalind Advisors, Inc.
25 Apr 24
4
Harry Kovelman
4 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
3
Heather C Getz
28 Mar 24
4
THOMAS F KIRK
18 Mar 24
4
DAVID A HENRY
13 Mar 24
4
Harry Kovelman
13 Mar 24
4
Micah Mitchell
13 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
4
Harry Kovelman
6 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
SC 13G/A
Rosalind Advisors, Inc.
15 Feb 24
SC 13G/A
Rosalind Advisors, Inc.
14 Feb 24
SC 13G/A
PACKER PAUL
14 Feb 24
SC 13G/A
HIRSCHMAN ORIN
7 Feb 24
4
Harry Kovelman
5 Feb 24
144
Notice of proposed sale of securities
2 Feb 24
4
Milton Mayo Morris
22 Jan 24
4/A
DAVID A HENRY
12 Jan 24
4/A
Harry Kovelman
12 Jan 24
4
Harry Kovelman
4 Jan 24
144
Notice of proposed sale of securities
2 Jan 24
4
THOMAS F KIRK
14 Dec 23
4
Thomas Aloysius Jr. Crowley
8 Dec 23
144
Notice of proposed sale of securities
8 Dec 23
4
Harry Kovelman
5 Dec 23
144
Notice of proposed sale of securities
4 Dec 23
144
Notice of proposed sale of securities
4 Dec 23
4
Thomas Aloysius Jr. Crowley
30 Nov 23
144
Notice of proposed sale of securities
28 Nov 23
4
Harry Kovelman
6 Nov 23
144
Notice of proposed sale of securities
3 Nov 23
4
Harry Kovelman
3 Oct 23
144
Notice of proposed sale of securities
2 Oct 23
4
Milton Mayo Morris
11 Sep 23
SC 13G/A
HIRSCHMAN ORIN
7 Sep 23
4
Harry Kovelman
6 Sep 23
144
Notice of proposed sale of securities
5 Sep 23